title: Two cases of anti-programmed cell death 1-associated bullous pemphigoid-like disease and eruptive keratoacanthomas featuring combined histopathology.
authors.affiliation: Medical University of South Carolina, Charleston, 29425, SC, USA.
authors.forename: J P
authors.initials: JP
authors.lastname: Bandino
authors.affiliation: Medical University of South Carolina, Charleston, 29425, SC, USA.
authors.forename: D M
authors.initials: DM
authors.lastname: Perry
authors.affiliation: Medical University of South Carolina, Charleston, 29425, SC, USA.
authors.forename: C E
authors.initials: CE
authors.lastname: Clarke
authors.affiliation: Medical University of South Carolina, Charleston, 29425, SC, USA.
authors.forename: R M
authors.initials: RM
authors.lastname: Marchell
authors.affiliation: Medical University of South Carolina, Charleston, 29425, SC, USA.
authors.forename: D M
authors.initials: DM
authors.lastname: Elston
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D000074322:Antineoplastic Agents, Immunological / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology*; D006801:Humans; D007636:Keratoacanthoma / Q000139:chemically induced*; D008297:Male; D010391:Pemphigoid, Bullous / Q000139:chemically induced*; D061026:Programmed Cell Death 1 Receptor / Q000037:antagonists & inhibitors
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000074322:Antineoplastic Agents, Immunological; D061026:Programmed Cell Death 1 Receptor; C582435:pembrolizumab